Welcome to LookChem.com Sign In|Join Free

CAS

  • or

120086-34-2

Post Buying Request

120086-34-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

120086-34-2 Usage

General Description

1-(4-Fluorophenyl)-1,2,3,4-tetrahydroisoquinoline is a chemical compound with a tetrahydroisoquinoline core structure and a fluorophenyl substituent. It is a potentially useful building block for the synthesis of various biologically active compounds due to its structural features. The presence of the fluorophenyl group can potentially confer specific properties to the molecule, such as altered reactivity or interactions with biological targets. 1-(4-Fluorophenyl)-1,2,3,4-tetrahydroisoquinoline may have potential applications in medicinal chemistry, pharmaceuticals, and materials science due to its unique structure and potential biological activities. Further research is needed to fully understand its chemical properties and potential applications.

Check Digit Verification of cas no

The CAS Registry Mumber 120086-34-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,0,8 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 120086-34:
(8*1)+(7*2)+(6*0)+(5*0)+(4*8)+(3*6)+(2*3)+(1*4)=82
82 % 10 = 2
So 120086-34-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H14FN/c16-13-7-5-12(6-8-13)15-14-4-2-1-3-11(14)9-10-17-15/h1-8,15,17H,9-10H2

120086-34-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-Fluorophenyl)-1,2,3,4-tetrahydroisoquinoline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:120086-34-2 SDS

120086-34-2Relevant articles and documents

Discovery of quinuclidine modulators of cellular progranulin

Burnett, Duane A.,Chen, Angela Y.-P.,Koenig, Gerhard,Lanter, James C.,Williamson, Toni,Blain, Jean-Fran?ois

, (2021/06/30)

Phenotypic screening of an annotated small molecule library identified the quinuclidine tetrahydroisoquinoline solifenacin (1) as a robust enhancer of progranulin secretion with single digit micromolar potency in a murine microglial (BV-2) cell line. Subsequent SAR development led to the identification of 29 with a 38-fold decrease in muscarinic receptor antagonist activity and a 10-fold improvement in BV-2 potency.

Diprotonative stabilization of ring-opened carbocationic intermediates: conversion of tetrahydroisoquinoline to triarylmethanes

Kurouchi, Hiroaki

, p. 8313 - 8316 (2020/08/17)

Superacid-promoted conversion of tetrahydroisoquinolines to triarylmethanes via tandem reactions of C-N bond scission, Friedel-Crafts alkylation, C-O bond scission, and electrophilic aromatic amidation was developed. Dication formation was important for stabilizing the ring-opened carbocationic intermediate, which is a new role for diprotonation in reaction mechanisms. This journal is

Phencyclidine-like Effects of Tetrahydroisoquinolines and Related Compounds

Gray, Nancy M.,Cheng, Brian K.,Mick, Stephen J.,Lair, Cecelia M.,Contreras, Patricia C.

, p. 1242 - 1248 (2007/10/02)

A series of 1,2,3,4-tetrahydroisoquinolines, tetrahydrothienopyridines, and related compounds were evaluated for their ability to inhibit binding of -1--N-allylnormetazocine to phencyclidine (PCP) and ? receptors, respectively.A representative series of compounds was evaluated in behavioral assays to determine the ability of the compounds to induce PCP-like stereotyped behavior and ataxia.All of the compounds caused stereotyped behavior and ataxia, indicating their agonist actions at the PCP site.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 120086-34-2